CAPR
Capricor Therapeutics Inc
NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY
$33.58
+3.45% today
Updated 2026-04-30
Market cap
$2.04B
P/E ratio
—
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
—
52W range
$4 – $40
Volume
1.3M
Capricor Therapeutics Inc (CAPR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |